Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Human Pathology|October 27, 2007
The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instabilityAileen M Houston, Julie M Michael-Robinson, Michael D Walsh, et al.Digestive Diseases and Sciences|September 8, 2019
Level of UV Exposure, Skin Type, and Age Are More Important than Thiopurine Use for Keratinocyte Carcinoma Development in IBD PatientsYang Wu, Simon Ghaly, Stephen Kerr, et al.The American Journal of Gastroenterology|August 2, 2008
ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneityElizabeth V Fowler, James Doecke, Lisa A Simms, et al.Inflammatory Bowel Diseases|January 26, 2013
Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn's diseaseJames D Doecke, Lisa A Simms, Zhen Zhen Zhao, et al.Journal of Crohn'S & Colitis|March 13, 2012
Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian studyKrupa Krishnaprasad, Jane M Andrews, Ian C Lawrance, et al.Journal of Gastroenterology and Hepatology|July 4, 2014
Smoking behaviour modifies IL23r-associated disease risk in patients with Crohn's diseaseJames D Doecke, Lisa A Simms, Zhen Zhen Zhao, et al.Inflammatory Bowel Diseases|January 28, 2005
The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interactionMarie Pierik, Huiying Yang, Michael M Barmada, et al.Journal of Crohn'S & Colitis|September 16, 2022
An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative ColitisSally Mortlock, Anton Lord, Grant Montgomery, et al.BMC Medical Genetics|August 31, 2017
Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score methodGuo-Bo Chen, Sang Hong Lee, Grant W Montgomery, et al.Inflammatory Bowel Diseases|June 11, 2013
Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's diseaseGrace Gathungu, Mi-Ok Kim, John P Ferguson, et al.Pageof 4